Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

The Lancet

Volumn 371, Issue 9628, 2008, Pages 1927-1935

  Sattar, Naveed ^a   McConnachie, Alex ^a   Shaper, A Gerald ^e   Blauw, Gerard J ^d   Buckley, Brendan M ^c   de Craen, Anton J ^d   Ford, Ian ^a   Forouhi, Nita G ^b   Freeman, Dilys J ^a   Jukema, J Wouter ^d   Lennon, Lucy ^e   Macfarlane, Peter W ^a   Murphy, Michael B ^c   Packard, Chris J ^a   Stott, David J ^a   Westendorp, Rudi G ^d   Whincup, Peter H ^f   Shepherd, James ^a   Wannamethee, S Goya ^e  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c University College Cork and INFANT Centre   (Ireland)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PRAVASTATIN; TRIACYLGLYCEROL;

AGED; ALGORITHM; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE;

EID: 46549089247     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60602-9     Document Type: Article

References (32)

1. Deedwania P., Barter P., Carmena R., et al. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet 368 (2006) 919-928
2. Sattar N., Gaw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
3. Wannamethee S., Shaper A., Lennon L., and Morris R. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165 (2005) 2644-2650
4. Gami A., Witt B., Howard D., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49 (2007) 403-414
5. Stern M., Williams K., Gonzalez-Villalpando C., Hunt K., and Haffner S. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 27 (2004) 2676-2681
6. Lawlor D., Smith G., and Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 49 (2006) 41-48
7. Wang J., Ruotsalainen S., Moilanen L., Lepisto P., Laakso M., and Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 28 (2007) 857-864
8. Ferrannini E. Metabolic syndrome: a solution in search of a problem. J Clin Endocrinol Metab 92 (2007) 396-398
9. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
10. Sattar N. The metabolic syndrome: should current criteria influence clinical practice?. Curr Opin Lipidol 17 (2006) 404-411
11. Gale E. The myth of the metabolic syndrome. Diabetologia 48 (2005) 1679-1683
12. Espinola-Klein C., Rupprecht H., Bickel C., et al. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol 99 (2007) 1623-1628
13. McNeill A., Katz R., Girman C., et al. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study. J Am Geriatr Soc 54 (2006) 1317-1324
14. Takahashi K., Bokura H., Kobayashi S., Iijima K., Nagai A., and Yamaguchi S. Metabolic syndrome increases the risk of ischemic stroke in women. Intern Med 46 (2007) 643-648
15. Shepherd J., Blauw G., Murphy M., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
16. Shaper A., Pocock S., Walker M., Cohen N., Wale C., and Thomson A. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) 283 (1981) 179-186
17. Shepherd J., Blauw G., Murphy M., et al. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol 84 (1999) 1192-1197
18. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
19. Alberti K., and Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
20. Emberson J., Whincup P., Walker M., Thomas M., and Alberti K. Biochemical measures in a population-based study: effect of fasting duration and time of day. Ann Clin Biochem 39 (2002) 493-501
21. Wannamethee S., Lowe G., Whincup P., Rumley A., Walker M., and Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105 (2002) 1785-1790
22. Wannamethee S., Shaper A., Lennon L., and Whincup P. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 86 (2007) 1339-1346
23. Walker M., Shaper A., Lennon L., and Whincup P. Twenty year follow-up of a cohort based in general practices in 24 British towns. J Public Health Med 22 (2000) 479-485
24. Rose G., Blackburn H., Gillum R., and Prineas R. Cardiovascular survey methods. 2nd edn (1982), World Health Organization, Geneva
25. Wilson P., D'Agostino R., Parise H., Sullivan L., and Meigs J. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
26. Schulze M., Hoffmann K., Boeing H., et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 30 (2007) 510-515
27. Lindstrom J., and Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26 (2003) 725-731
28. Pepe M., Janes H., Longton G., Leisenring W., and Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159 (2004) 882-890
29. Chien K., Hsu H., Sung F., Su T., Chen M., and Lee Y. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 194 (2007) 214-221
30. Packard C., Ford I., Robertson M., et al. Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 112 (2005) 3058-3065
31. Boshuizen H., Izaks G., van Buuren S., and Ligthart G. Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ 316 (1998) 1780-1784
32. Jeppesen J., Hansen T., Rasmussen S., Ibsen H., Torp-Pedersen C., and Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 49 (2007) 2112-2119